KR100976778B1 - 1-(2'-플루오로-베타-엘-아라비노푸라노실)티민의 황 유도체를 유효 활성 성분으로 하는 b형 간염 바이러스 치료제 - Google Patents
1-(2'-플루오로-베타-엘-아라비노푸라노실)티민의 황 유도체를 유효 활성 성분으로 하는 b형 간염 바이러스 치료제 Download PDFInfo
- Publication number
- KR100976778B1 KR100976778B1 KR1020030024280A KR20030024280A KR100976778B1 KR 100976778 B1 KR100976778 B1 KR 100976778B1 KR 1020030024280 A KR1020030024280 A KR 1020030024280A KR 20030024280 A KR20030024280 A KR 20030024280A KR 100976778 B1 KR100976778 B1 KR 100976778B1
- Authority
- KR
- South Korea
- Prior art keywords
- virus
- fluoro
- hepatitis
- formula
- fmau
- Prior art date
Links
Classifications
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
- H05B6/00—Heating by electric, magnetic or electromagnetic fields
- H05B6/64—Heating using microwaves
- H05B6/6414—Aspects relating to the door of the microwave heating apparatus
Landscapes
- Physics & Mathematics (AREA)
- Electromagnetism (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
L-FMAU 황유도체 농도(μM) |
HepG2 2.2.15 세포 | |
흡광도 값 평균 | % of control | |
Control | 2.343 | 100 |
180 | 2.350 | 100.3 |
360 | 1.859 | 79.3 |
720 | 1.106 | 47.2 |
1440 | 0.197 | 8.4 |
L-FMAU 황유도체 농도(μM) |
HepG2 2.2.15 세포 |
HBsAg 의 생성저해율 (%) | |
11.25 | 10.9 |
22.5 | 15.1 |
45 | 13 |
90 | 17.7 |
180 | 37 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030024280A KR100976778B1 (ko) | 2003-04-17 | 2003-04-17 | 1-(2'-플루오로-베타-엘-아라비노푸라노실)티민의 황 유도체를 유효 활성 성분으로 하는 b형 간염 바이러스 치료제 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030024280A KR100976778B1 (ko) | 2003-04-17 | 2003-04-17 | 1-(2'-플루오로-베타-엘-아라비노푸라노실)티민의 황 유도체를 유효 활성 성분으로 하는 b형 간염 바이러스 치료제 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040090257A KR20040090257A (ko) | 2004-10-22 |
KR100976778B1 true KR100976778B1 (ko) | 2010-08-18 |
Family
ID=37371411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020030024280A KR100976778B1 (ko) | 2003-04-17 | 2003-04-17 | 1-(2'-플루오로-베타-엘-아라비노푸라노실)티민의 황 유도체를 유효 활성 성분으로 하는 b형 간염 바이러스 치료제 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100976778B1 (ko) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990076091A (ko) * | 1998-03-27 | 1999-10-15 | 윤종여 | 2'-플루오로-5-메틸-β-L-아라비노푸라노실유리딘의 제조방법 |
KR100247505B1 (ko) | 1997-07-23 | 2000-03-15 | 쥬디 시. 버틀러 | 2'-플루오로-5-메틸-β-L-아라비노푸라노실유리딘의 제조방법 |
KR100487992B1 (ko) * | 2001-10-25 | 2005-05-09 | 부광약품 주식회사 | 2'-플루오로-5-메틸-β-엘-아라비노푸라노실유리딘의 황유도체 |
-
2003
- 2003-04-17 KR KR1020030024280A patent/KR100976778B1/ko active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100247505B1 (ko) | 1997-07-23 | 2000-03-15 | 쥬디 시. 버틀러 | 2'-플루오로-5-메틸-β-L-아라비노푸라노실유리딘의 제조방법 |
KR19990076091A (ko) * | 1998-03-27 | 1999-10-15 | 윤종여 | 2'-플루오로-5-메틸-β-L-아라비노푸라노실유리딘의 제조방법 |
KR100487992B1 (ko) * | 2001-10-25 | 2005-05-09 | 부광약품 주식회사 | 2'-플루오로-5-메틸-β-엘-아라비노푸라노실유리딘의 황유도체 |
Non-Patent Citations (1)
Title |
---|
Journal of Medicinal Chemistry, 1987, Vol. 30, pp. 226-229 |
Also Published As
Publication number | Publication date |
---|---|
KR20040090257A (ko) | 2004-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI111370B (fi) | Menetelmä virusvastaisten monoesteriyhdisteiden valmistamiseksi | |
KR102057751B1 (ko) | 테노포비르 전구약물 및 그의 약학적 용도 | |
EA007178B1 (ru) | Производные beta-d-нуклеозида в качестве лекарственного средства для лечения инфекции вируса гепатита c у хозяина | |
US20130303747A1 (en) | Pyrimidine nucleoside derivatives, synthesis methods and uses thereof for preparing anti-tumor and anti-virus medicaments | |
KR100272732B1 (ko) | 항바이러스성을 나타내는 누클레오시드 및 누클레오시드 유사체의 아실 유도체 및 이 화합물을 함유하는 약학 조성물 | |
CZ211496A3 (cs) | L-nukleosidy pro léčení hepatitidy viru B a Epstain-Bar viru | |
EA011868B1 (ru) | Амидное пролекарство гемцитабина, композиции на его основе и его применение | |
WO2017219915A1 (zh) | 一种腺嘌呤衍生物的膦酸酯前药及其在医药上的应用 | |
JP2023536685A (ja) | アンギオポエチン様3(ANGPTL3)のsiRNA及びその用途 | |
CA2436958A1 (fr) | Derives d'acyclonucleosides pyrimidiniques, leur procede de preparation et leur utilisation | |
KR100976778B1 (ko) | 1-(2'-플루오로-베타-엘-아라비노푸라노실)티민의 황 유도체를 유효 활성 성분으로 하는 b형 간염 바이러스 치료제 | |
JP5185823B2 (ja) | がん治療用ジオキソラン誘導体 | |
CN111187222B (zh) | 一种取代嘧啶类衍生物及其制备方法和应用 | |
CN115141206B (zh) | 一种ɑ-硫辛酸石蒜碱偶联物及其制备方法和应用 | |
CN110655546B (zh) | 索非布韦衍生物及其制备方法和应用 | |
KR101323698B1 (ko) | Azt의 변형된 5'-포스포네이트 - 잠재적 항바이러스제 | |
JPH07165748A (ja) | 複素環ケトン骨格を有する誘導体および抗ウイルス剤 | |
JPH01308295A (ja) | 2′―デオキシ―5―フルオロウリジン誘導体、その製造方法及びそれを有効成分として含有する抗腫瘍剤 | |
FR2953835A1 (fr) | Nouveaux composes antiviraux, analogues de la 3-deazauridine aryles en position c3 | |
JPS58185523A (ja) | 新規な5−フルオロ−2′−デオキシ−β−ウリジン誘導体を含有する制癌剤 | |
JPH11255756A (ja) | 4−(置換アミノカルボニル)オキサゾール誘導体及び抗癌剤 | |
IE930047A1 (en) | Chemical compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130704 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20140704 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20150626 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20170705 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20180628 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20190627 Year of fee payment: 10 |